| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/12/2005 | CN1562079A Broad spectrum bacteriostat and sterilizing of silver ion nano porous material |
| 01/12/2005 | CN1562030A Gatiflxacin eye gels based on HPMC medium and its preparing method |
| 01/12/2005 | CN1562021A Method for improving liposome enveloping rate of camptothecine or its derivatives |
| 01/12/2005 | CN1561987A Nano micro ball with taxol capable of biologically degradating high molecule and its preparing method |
| 01/12/2005 | CN1561974A Medicinal composition containing cyclodextrin and phenylpropyl alcohol substance |
| 01/12/2005 | CN1561972A Cell necrosis signal identifying type intelligent adminisration carrier |
| 01/12/2005 | CN1561969A Co-loaded gene and medicine super micro carrier particles and its preparing method |
| 01/12/2005 | CN1561968A Antibody and polyalkylene glycol-bonded liposome |
| 01/12/2005 | CN1561964A Process for producing polyvinyl alcohol particle embolism agent |
| 01/12/2005 | CN1561963A Enteric coatel material coated anti-inflammation agent insert layer hydrotalcite and its preparing method |
| 01/12/2005 | CN1561962A Implanted degradable high molecular material medicine control-release carrier and its preparing process |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1183972C Wound covering material capable of promoting wound healing |
| 01/12/2005 | CN1183967C Carrier of externally-applied medicines and its preparing process |
| 01/12/2005 | CN1183961C Remedies for bone metabolic errors |
| 01/12/2005 | CN1183908C Injection medication combination of nimodiping and its preparing method |
| 01/12/2005 | CN1183904C Chewable soft capsule having improved administration properties and process for producing same |
| 01/12/2005 | CN1183903C Orally dispersible tablet with low friability and method for preparing same |
| 01/12/2005 | CN1183902C Process for preparing oral calcium compositions |
| 01/12/2005 | CN1183901C Pharmaceutical compositions capable of being gelled |
| 01/12/2005 | CN1183900C Nicotine inhaler |
| 01/12/2005 | CN1183894C Composition for external use |
| 01/11/2005 | US6841617 Thermogelling biodegradable aqueous polymer solution |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841545 Heat resistance; anticancer drug |
| 01/11/2005 | US6841539 Oligonucleotide admixed with a topical penetration enhancer, isopropyl myristate |
| 01/11/2005 | US6841535 Peptide-mediated transfection agents and methods of use |
| 01/11/2005 | US6841181 Encapsulated multifunctional biologically active food component, process for its production and its use |
| 01/11/2005 | US6840244 Condom with an erectogenic composition |
| 01/11/2005 | CA2284051C Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates |
| 01/11/2005 | CA2269783C Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2213719C Transparent rapid-release preparation of non-steroid analgesics |
| 01/11/2005 | CA2200068C A preparation for external use and a patch having the preparation attached thereto |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |
| 01/06/2005 | WO2005001038A2 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | WO2005001023A2 Method and carrier complexes for delivering molecules to cells |
| 01/06/2005 | WO2005001022A2 Methods and compositions for enhancing immune response |
| 01/06/2005 | WO2005000884A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | WO2005000360A2 Peg derivatives having an amidocarbonate linkage |
| 01/06/2005 | WO2005000359A2 Chemically-modified human growth hormone conjugates |
| 01/06/2005 | WO2005000357A2 Chemical combination and method for increasing delivery of coenzyme q 10 |
| 01/06/2005 | WO2005000346A1 Carrier proteins for vaccines |
| 01/06/2005 | WO2005000334A1 Abuse resistant amphetamine compounds |
| 01/06/2005 | WO2005000324A2 Colloidal silver composition having antimicrobial properties |
| 01/06/2005 | WO2005000316A1 External preparation for improving coital function |
| 01/06/2005 | WO2005000287A1 External preparation for athlete's foot treatment |
| 01/06/2005 | WO2005000280A2 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin |
| 01/06/2005 | WO2005000277A1 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix |
| 01/06/2005 | WO2005000271A1 Method for improving stability and shelf-life of liposome complexes |
| 01/06/2005 | WO2005000269A1 Pharmaceutical formulations comprising a proton pump inhibitor |
| 01/06/2005 | WO2005000222A2 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 01/06/2005 | WO2005000210A2 Synthesis of high molecular weight iron-saccharidic complexes |
| 01/06/2005 | WO2004104491A3 Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
| 01/06/2005 | WO2004098620A8 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer |
| 01/06/2005 | WO2004092213B1 Gene expressed in prostate cancer, methods and use thereof |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004087141B1 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases |
| 01/06/2005 | WO2004078216A3 Use of a tricyclic antidepressant drug for promoting endocytosis |
| 01/06/2005 | WO2004076474A3 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 01/06/2005 | WO2003088913A8 Peptide deformylase activated prodrugs |
| 01/06/2005 | WO2003032912A9 Treatment of cns disorders using cns target modulators |
| 01/06/2005 | WO2003032907A9 High-concentration protein formulations and method of manufacture |
| 01/06/2005 | US20050004356 Linker nucleoside, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004274 Ester with one or more triblock copolymers having rigid and elastic sections; mineral oil free; vehicles for topical materials |
| 01/06/2005 | US20050004226 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/06/2005 | US20050004184 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones |
| 01/06/2005 | US20050004171 Increasing blood absorption of proton pump inhibitor; adjusting stomach gastric fluid pH with buffering agent to inhibit acid degradation |
| 01/06/2005 | US20050004084 Aspirin-containing trasdermal pharmaceutical composition for the treatment of calcification |
| 01/06/2005 | US20050004072 Methods and compositions for poly-beta-1-4-N-acetylglucosamine cell therapy system |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004055 Synergistic process; electrical stimulation; administering hyaluronidase |
| 01/06/2005 | US20050004031 Complement inhibitor |
| 01/06/2005 | US20050004020 Anchoring compound to surface of target cells; protease inhibitors |
| 01/06/2005 | US20050004019 Neuroprotective peptides and uses thereof |
| 01/06/2005 | US20050004010 Complex with antitumor agents; therapy, diagnosis |
| 01/06/2005 | US20050004002 Mixture of drug with carrier such as protein; side effect reduction |
| 01/06/2005 | US20050003483 Major histocompatibility complex peptide ligand for use in identifying modulators which prevent transplantation and autoimmunity disorders; immunotherapy |
| 01/06/2005 | US20050003469 Immunoglobulin specific to abnormally proliferating cells for use in prevention and treatment of cancer disorders; immunotherapy; immunodiagnostics |
| 01/06/2005 | US20050003466 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050003465 Monoclonal abtibody specific to prostate cell-surface antigen associated with androgen-dependent and androgen-independent prostate tumors for use in prevention, diagnosis and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | US20050003431 Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor |
| 01/06/2005 | US20050003021 Bowel cleansing agent |
| 01/06/2005 | US20050003015 Producing isoleucine, leucine and valine containing particles having reduced bitterness and odor; small volume dose |
| 01/06/2005 | US20050003014 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 01/06/2005 | US20050003013 Controlled rate and duration of release; degradable gel with controlled saturated moisture content |
| 01/06/2005 | US20050003009 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| 01/06/2005 | US20050003003 Modulation of release from dry powder formulations |
| 01/06/2005 | US20050003002 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 01/06/2005 | US20050003001 Including floating agent |
| 01/06/2005 | US20050002998 Method for improving stability and shelf-life of liposome complexes |
| 01/06/2005 | US20050002992 Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| 01/06/2005 | US20050002987 Transnasal microemulsions containing diazepam |
| 01/06/2005 | US20050002986 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 01/06/2005 | US20050002983 Drug eluting stents having different symptom reducing agents |
| 01/06/2005 | US20050002977 Novel powdered polymer, method for its preparation, and use as a thickener |
| 01/06/2005 | US20050002970 Enhancing flowability and lubricity; artificial tears, ocular lubricants |
| 01/06/2005 | US20050002963 Active ingredient bound to or encapsulated within exine coating of spores from plant, moss, fungus or algae; oral delivery with rapid release to blood stream |